Verastem Inc (VSTM)
11.50
-0.12
(-0.99%)
USD |
NASDAQ |
May 21, 10:13
Verastem Cash and Short Term Investments (Quarterly): 110.12M for March 31, 2024
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 110.12M |
December 31, 2023 | 137.13M |
September 30, 2023 | 165.66M |
June 30, 2023 | 183.09M |
March 31, 2023 | 111.20M |
December 31, 2022 | 87.89M |
September 30, 2022 | 103.98M |
June 30, 2022 | 94.31M |
March 31, 2022 | 106.28M |
December 31, 2021 | 100.26M |
September 30, 2021 | 103.42M |
June 30, 2021 | 108.14M |
March 31, 2021 | 121.10M |
December 31, 2020 | 141.23M |
September 30, 2020 | 170.47M |
June 30, 2020 | 125.33M |
March 31, 2020 | 135.06M |
December 31, 2019 | 75.51M |
September 30, 2019 | 160.23M |
June 30, 2019 | 187.25M |
March 31, 2019 | 211.66M |
December 31, 2018 | 249.65M |
September 30, 2018 | 145.64M |
June 30, 2018 | 168.69M |
March 31, 2018 | 64.22M |
Date | Value |
---|---|
December 31, 2017 | 86.67M |
September 30, 2017 | 60.26M |
June 30, 2017 | 57.92M |
March 31, 2017 | 72.57M |
December 31, 2016 | 80.90M |
September 30, 2016 | 86.88M |
June 30, 2016 | 92.87M |
March 31, 2016 | 99.54M |
December 31, 2015 | 110.26M |
September 30, 2015 | 120.47M |
June 30, 2015 | 132.09M |
March 31, 2015 | 132.07M |
December 31, 2014 | 92.68M |
September 30, 2014 | 93.37M |
June 30, 2014 | 98.60M |
March 31, 2014 | 105.64M |
December 31, 2013 | 101.31M |
September 30, 2013 | 99.93M |
June 30, 2013 | 57.45M |
March 31, 2013 | 66.72M |
December 31, 2012 | 56.58M |
September 30, 2012 | 46.85M |
June 30, 2012 | 38.69M |
March 31, 2012 | 41.07M |
December 31, 2011 | 47.81M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
75.51M
Minimum
Dec 2019
187.25M
Maximum
Jun 2019
126.38M
Average
116.15M
Median
Cash and Short Term Investments (Quarterly) Benchmarks
Johnson & Johnson | 26.22B |
Geron Corp | 443.05M |
Altimmune Inc | 182.02M |
Oragenics Inc | 2.072M |
Actinium Pharmaceuticals Inc | 84.06M |